Women are significantly more affected by Alzheimer’s disease, representing nearly two-thirds of the 7.2 million individuals diagnosed with this condition in the United States. Recent research has highlighted a potential protective factor specifically for women: omega-3 fatty acids, which are well-regarded for their contributions to brain health.
In a comprehensive study published in the journal Alzheimer’s & Dementia, researchers examined blood lipid profiles from over 800 participants. Their findings revealed a critical distinction: women diagnosed with Alzheimer’s had lower levels of unsaturated fats that transport omega-3 fatty acids compared to their male counterparts.
Omega-3 fatty acids, a category of polyunsaturated fats that are vital for strengthening and building brain cells, cannot be synthesized by the body, necessitating their absorption through diet or supplements. Until now, the question of how these fats influence Alzheimer’s progression had remained largely unexplored.
Lead author Cristina Legido-Quigley, PhD, affiliated with King’s College London, emphasized the implications of these findings, indicating that omega-3 fatty acids could play a unique role in the progression of Alzheimer’s, underscoring the need for tailored approaches in understanding and treating the disease based on sex.
Legido-Quigley noted in an interview with Health, “This suggests we need sex-specific approaches to understanding, diagnosing, and potentially treating Alzheimer’s disease.”
The impetus for this research stemmed from previous studies indicating that up to 45% of dementia cases might be preventable, with 7% attributable to high levels of LDL cholesterol, commonly referred to as “bad” cholesterol. This prior work highlighted the relevance of lipid metabolism in maintaining brain health, prompting further investigation.
This recent study involved a detailed analysis of blood samples from 841 individuals, assessing over 700 different lipids. Participants included those enrolled in ANMerge, an initiative focused on identifying biomarkers for Alzheimer’s. Among them, 306 had been diagnosed with Alzheimer’s, while 165 were experiencing mild cognitive impairment.
Key findings revealed that women with Alzheimer’s exhibited elevated levels of saturated (unhealthy) lipids while simultaneously displaying reduced levels of unsaturated lipids responsible for transporting omega-3s. In contrast, no notable differences were identified between men, regardless of their Alzheimer’s status, suggesting that lipid metabolic processes could be uniquely influential for women.
Timothy Chang, MD, PhD, an assistant professor of neurology at UCLA’s Mary S. Easton Center for Alzheimer’s Research and Care, commended the study for its rigorous design and its contributions to understanding the lipids associated with Alzheimer’s disease in women.
While the study indicates a correlation between omega-3s and Alzheimer’s development in women, it’s critical to point out that it does not establish causation. The results may not be entirely representative of the general population, as all participants were older adults from Europe.
Looking to the future, Legido-Quigley hopes to conduct clinical trials involving younger women to examine lipid levels from the onset, providing further clarity into the protective mechanisms of omega-3s. The reasoning behind their heightened effectiveness for women remains an area ripe for exploration.
Although it is premature to advise women to increase their intake of omega-3s specifically to mitigate Alzheimer’s risk, incorporating them into a balanced diet continues to be beneficial for overall health. Experts recommend obtaining omega-3 fatty acids primarily from food sources rather than supplements. Key dietary sources include:
- Fatty cold-water fish (like salmon, mackerel, and sardines)
- Walnuts
- Chia seeds
- Flaxseeds
- Algal oil
